77191-36-7 Usage
Description
Nefiracetam is a nootropic drug belonging to the racetam family of cognitive enhancers. It is known for its potential to improve cognitive functions, particularly memory and learning capabilities. Nefiracetam works by modulating the activity of neurotransmitters in the brain, leading to enhanced synaptic plasticity and neural communication.
Uses
Used in Pharmaceutical Industry:
Nefiracetam is used as a cognitive enhancer for improving memory and learning capabilities. It is particularly beneficial for individuals experiencing cognitive decline or those looking to enhance their cognitive performance.
Used in Neurological Applications:
Nefiracetam is used as a therapeutic agent for treating post-ischemia evoke-nonconvulsive seizures. It achieves this by altering the levels of pro-inflammatory cytokines, which play a role in the development and progression of such seizures.
Biological Activity
Cognitive enhancer that displays various pharmacological effects. Activates L/N-type calcium channels, cholinergic, monoaminergic and GABAergic systems. Displays potent neuroprotective action in the retinal ischemia-reperfusion model in vivo .
Check Digit Verification of cas no
The CAS Registry Mumber 77191-36-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,7,1,9 and 1 respectively; the second part has 2 digits, 3 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 77191-36:
(7*7)+(6*7)+(5*1)+(4*9)+(3*1)+(2*3)+(1*6)=147
147 % 10 = 7
So 77191-36-7 is a valid CAS Registry Number.
InChI:InChI=1/C14H18N2O2/c1-10-5-3-6-11(2)14(10)15-12(17)9-16-8-4-7-13(16)18/h3,5-6H,4,7-9H2,1-2H3,(H,15,17)
77191-36-7Relevant articles and documents
Preparation method of drug niracetam for treating's disease (by machine translation)
-
Paragraph 0026; 0028; 0029; 0031; 0032; 0034; 0035; 0037, (2019/08/12)
The invention belongs to the field, and particularly discloses a preparation method. of medicine for treating's disease. By N' N N-dicarbonyl imidazole (CDI) to activate carboxyl in 2 - oxopyrrolidine acetic acid, the reaction activity, the reaction rate, the side reaction are reduced, the obtained product yield is high, the purity is high, the production cost, and the industrial production. (by machine translation)
Process for preparing pyrrolidinylacetamide derivatives
-
, (2008/06/13)
A process for preparing a 2-(1-pyrrolidinyl)acetamide derivative useful as a cerebral function improving agent is disclosed, comprising reacting a halogenoacetamide derivative with substituted or unsubstituted 2-pyrrolidinone, the halogenoacetamide derivative being prepared by reacting an amine and a halogenoacetyl chloride. High yields of the intermediate compound as well as the final product are attained at low cost.